Quoin Pharmaceuticals Ltd is a biopharmaceutical company based in Ashburn, VA, dedicated to developing therapeutic products for rare diseases. With a strong focus on patient well-being, the company aims to address the challenges faced by individuals living with rare diseases, such as Netherton Syndrome, which affects approximately 300 million people worldwide. Quoin Pharmaceuticals is conducting ongoing clinical trials for QRX003, a potential treatment for Netherton Syndrome, and has established exclusive international marketing and distribution partnerships to ensure global accessibility to their rare disease products.
Driven by the courage of patients, their families, and care teams, Quoin Pharmaceuticals is motivated to make a positive impact in the field of rare diseases. Their business strategy revolves around placing patients at the center of their operations, with plans to establish a commercial infrastructure in the US and Europe. Committed to innovation, the company has filed patent applications for a novel combination product for Netherton Syndrome, further demonstrating their dedication to improving the lives of those affected by rare diseases.
Generated from the website
